RE:RE:RE:RE:RE:RE:Cant say I like the price.Hi Balain,
great post as always! I am a shareholder since 2005 or 12 long years! and like you, and other longs, I’m sure, feel the same way about how things do not appear to be lining up as anticipated.
Speaking of which, here is an example (one of many) where things do not materialize as originally announced by PLI.
I wrote Fred back on August 25 regarding the SRAM deal.
News release
March 30, 2017
SRAM, a leading investment group in healthcare in China, will provide $23 million in 2017, $13 million upfront and $10 million expected in H2 2017, to secure an initial 17% ownership of Prometic ChinaCo, with a right to increase it up to 25% with a further $10 million investment related to milestones expected in
August 14, 2017
SRAM’s initial funding of $33 million is earmarked for the clinical development of the Products, currently on-going outside China. Of the $33 million, $23 million is receivable in the second half of 2017
Fred, two things I would like answered;
1. What happened to $13 million upfront?
2. We are in the 2nd half. What is the date this payment is expected?
Fred’s reply, Sept 7: These should appear in the Q3 financial statements to be disclosed mid-November
I comfort myself by saying that it is all moving along as planned, it’s just taking longer than expected.
I also agree that there seems to be no apparent evidence that institutional investment firms are promoting/buying the stock! For example, what is Cantor Fitzgerald doing with the shares they acquired in June? As a matter of fact, I entered Prometic in their search engine and nothing came up! I guess they are holding out for the opportune time, possibly once approval is granted and/or the upturn begins.
Anyhow, very frustrating to see my money just stagnating because I do not have the balls to risk playing the stock.
Onwards & Upwards as PL would say!
Cheers
Aldo